PURPOSE: The goal of the study was to compare the effects of different assisted ventilation modes with pressure controlled ventilation (PCV) on lung histology, arterial blood gases, inflammatory and fibrogenic mediators in experimental acute lung injury (ALI). METHODS: Paraquat-induced ALI rats were studied. At 24 h, animals were anaesthetised and further randomized as follows (n = 6/group): (1) pressure controlled ventilation mode (PCV) with tidal volume (V (T)) = 6 ml/kg and inspiratory to expiratory ratio (I:E) = 1:2; (2) three assisted ventilation modes: (a) assist-pressure controlled ventilation (APCV1:2) with I:E = 1:2, (b) APCV1:1 with I:E = 1:1; and (c) biphasic positive airway pressure and pressure support ventilation (BiVent + PSV), and (3) spontaneous breathing without PEEP in air. PCV, APCV1:1, and APCV1:2 were set with P (insp) = 10 cmH(2)O and PEEP = 5 cmH(2)O. BiVent + PSV was set with two levels of CPAP [inspiratory pressure (P (High) = 10 cmH(2)O) and positive end-expiratory pressure (P (Low) = 5 cmH(2)O)] and inspiratory/expiratory times: T (High) = 0.3 s and T (Low) = 0.3 s. PSV was set as follows: 2 cmH(2)O above P (High) and 7 cmH(2)O above P (Low). All rats were mechanically ventilated in air and PEEP = 5 cmH(2)O for 1 h. RESULTS: Assisted ventilation modes led to better functional improvement and less lung injury compared to PCV. APCV1:1 and BiVent + PSV presented similar oxygenation levels, which were higher than in APCV1:2. Bivent + PSV led to less alveolar epithelium injury and lower expression of tumour necrosis factor-alpha, interleukin-6, and type III procollagen. CONCLUSIONS: In this experimental ALI model, assisted ventilation modes presented greater beneficial effects on respiratory function and a reduction in lung injury compared to PCV. Among assisted ventilation modes, Bi-Vent + PSV demonstrated better functional results with less lung damage and expression of inflammatory mediators.
PURPOSE: The goal of the study was to compare the effects of different assisted ventilation modes with pressure controlled ventilation (PCV) on lung histology, arterial blood gases, inflammatory and fibrogenic mediators in experimental acute lung injury (ALI). METHODS:Paraquat-induced ALI rats were studied. At 24 h, animals were anaesthetised and further randomized as follows (n = 6/group): (1) pressure controlled ventilation mode (PCV) with tidal volume (V (T)) = 6 ml/kg and inspiratory to expiratory ratio (I:E) = 1:2; (2) three assisted ventilation modes: (a) assist-pressure controlled ventilation (APCV1:2) with I:E = 1:2, (b) APCV1:1 with I:E = 1:1; and (c) biphasic positive airway pressure and pressure support ventilation (BiVent + PSV), and (3) spontaneous breathing without PEEP in air. PCV, APCV1:1, and APCV1:2 were set with P (insp) = 10 cmH(2)O and PEEP = 5 cmH(2)O. BiVent + PSV was set with two levels of CPAP [inspiratory pressure (P (High) = 10 cmH(2)O) and positive end-expiratory pressure (P (Low) = 5 cmH(2)O)] and inspiratory/expiratory times: T (High) = 0.3 s and T (Low) = 0.3 s. PSV was set as follows: 2 cmH(2)O above P (High) and 7 cmH(2)O above P (Low). All rats were mechanically ventilated in air and PEEP = 5 cmH(2)O for 1 h. RESULTS: Assisted ventilation modes led to better functional improvement and less lung injury compared to PCV. APCV1:1 and BiVent + PSV presented similar oxygenation levels, which were higher than in APCV1:2. Bivent + PSV led to less alveolar epithelium injury and lower expression of tumour necrosis factor-alpha, interleukin-6, and type III procollagen. CONCLUSIONS: In this experimental ALI model, assisted ventilation modes presented greater beneficial effects on respiratory function and a reduction in lung injury compared to PCV. Among assisted ventilation modes, Bi-Vent + PSV demonstrated better functional results with less lung damage and expression of inflammatory mediators.
Authors: Peter M Spieth; Alysson R Carvalho; Paolo Pelosi; Catharina Hoehn; Christoph Meissner; Michael Kasper; Matthias Hübler; Matthias von Neindorff; Constanze Dassow; Martina Barrenschee; Stefan Uhlig; Thea Koch; Marcelo Gama de Abreu Journal: Am J Respir Crit Care Med Date: 2009-01-16 Impact factor: 21.405
Authors: A Esteban; I Alía; M J Tobin; A Gil; F Gordo; I Vallverdú; L Blanch; A Bonet; A Vázquez; R de Pablo; A Torres; M A de La Cal; S Macías Journal: Am J Respir Crit Care Med Date: 1999-02 Impact factor: 21.405
Authors: R Andrew Shanely; Darin Van Gammeren; Keith C Deruisseau; A Murat Zergeroglu; Michael J McKenzie; Kevin E Yarasheski; Scott K Powers Journal: Am J Respir Crit Care Med Date: 2004-08-05 Impact factor: 21.405
Authors: Hermann Wrigge; Jörg Zinserling; Peter Neumann; Thomas Muders; Anders Magnusson; Christian Putensen; Göran Hedenstierna Journal: Crit Care Date: 2005-11-16 Impact factor: 9.097
Authors: Cíntia L Santos; Lillian Moraes; Raquel S Santos; Mariana G Oliveira; Johnatas D Silva; Tatiana Maron-Gutierrez; Débora S Ornellas; Marcelo M Morales; Vera L Capelozzi; Nelson Jamel; Paolo Pelosi; Patricia R M Rocco; Cristiane S N B Garcia Journal: Intensive Care Med Date: 2012-01-11 Impact factor: 17.440
Authors: Alessandra F Thompson; Lillian Moraes; Nazareth N Rocha; Marcos V S Fernandes; Mariana A Antunes; Soraia C Abreu; Cintia L Santos; Vera L Capelozzi; Cynthia S Samary; Marcelo G de Abreu; Felipe Saddy; Paolo Pelosi; Pedro L Silva; Patricia R M Rocco Journal: PLoS One Date: 2021-08-20 Impact factor: 3.240
Authors: Pedro L Silva; Fernanda F Cruz; Livia C Fujisaki; Gisele P Oliveira; Cynthia S Samary; Debora S Ornellas; Tatiana Maron-Gutierrez; Nazareth N Rocha; Regina Goldenberg; Cristiane S N B Garcia; Marcelo M Morales; Vera L Capelozzi; Marcelo Gama de Abreu; Paolo Pelosi; Patricia R M Rocco Journal: Crit Care Date: 2010-06-14 Impact factor: 9.097
Authors: Massimo Antonelli; Elie Azoulay; Marc Bonten; Jean Chastre; Giuseppe Citerio; Giorgio Conti; Daniel De Backer; Herwig Gerlach; Goran Hedenstierna; Michael Joannidis; Duncan Macrae; Jordi Mancebo; Salvatore M Maggiore; Alexandre Mebazaa; Jean-Charles Preiser; Jerôme Pugin; Jan Wernerman; Haibo Zhang Journal: Intensive Care Med Date: 2011-01-04 Impact factor: 17.440
Authors: Sarah M McMullen; Maureen Meade; Louise Rose; Karen Burns; Sangeeta Mehta; Robert Doyle; Dietrich Henzler Journal: PLoS One Date: 2012-08-16 Impact factor: 3.240